Heparin Sodium [9041-08-1]
H1658
Overview
- SupplierLKT Laboratories
- Product NameHeparin Sodium [9041-08-1]
- Delivery Days Customer7
- Estimated Purity≥98%
- FormatSoluble in water (50mg/mL) and saline solutions. Practically insoluble in alcohol, acetone, benzene, chloroform or ether. DMSO <1 mg/mL
- Scientific DescriptionEndogenous glycosaminoglycan that is produced by mast cells and basophils; Factor Xa inhibitor.; Heparin sodium salt, Heprinar, Hepsal, Monoparin, Panheprin, Liquaemin Sodium, Minihep, Thrombophob, Unihep
- Storage InstructionHygroscopic. In DMSO at +4 for 2 weeks at -80 for 6 months.; 4°C
- UNSPSC12352200
References
- Murray PB, Lax I, Reshetnyak A, et al. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK. Sci Signal. 2015 Jan 20;8(360):ra6. PMID: 25605972. Brkljacic J, Pauk M, Erjavec I, et al. Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity. Int Orthop. 2013 Mar;37(3):529-41. PMID: 23307015. Chuang YJ, Swanson R, Raja SM, et al. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J Biol Chem. 2001 May 4;276(18):14961-71. PMID: 11278930. Yokoyama T, Takeuchi A, Yamamoto M, et al. Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease. Neurosci Lett. 2011 Jul 8;498(2):119-123. PMID: 21565253.